RxDoctor Payments Data

Jonathan Forman, MD

Otolaryngology/Facial Plastic Surgery · Tampa, FLNPI 1144259078

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 64 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 24 manufacturers reported payments, led by Merz North America, Inc. at 31.5% of the total. Reporting peaked in 2019 at $1,014 and has fallen 58.6% since, to $419 in 2025.

$2,756in general payments, 2019–2025

Across 64 payments — averaging $43.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merz North America, Inc.$868
  • Aerin Medical Inc.$460
  • Johnson & Johnson$293
  • Spirair, Inc.$154
  • Stryker$134
  • Sanofi$118
  • plus $728 from 18 others

What the payments were for

  • Food & beverage$2,756100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,756 in reported general payments places this provider in the 55th percentile of 48 otolaryngology/facial plastic surgery providers in Florida.

See all otolaryngology/facial plastic surgery providers in Florida

Medicare billing

Part B allowed, 2024
$259,289
Medicare patients
340
Services billed
1,534

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ipratropium Bromide152$4,403
Fluticasone Propionate132$2,087
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth15$1,729
Azelastine Hcl64$1,588
Levocetirizine Dihydrochloride65$1,059
ValacyclovirValacyclovir Hcl15$891
Fluocinolone Acetonide Oil12$353
Famotidine19$327
Omeprazole25$281
Prednisone30$219
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav18$194
Montelukast Sodium11$191
Mupirocin26$189
Acetaminophen-CodeineAcetaminophen With Codeine18$75
Fluconazole11$64

Paid to pharmacies, not to this prescriber.

Other otolaryngology/facial plastic surgery in Tampa

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →